ArticleFrontiers in psychiatry2021
Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
13.9field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 80 citations in OpenAlex.
- Effects of exercise of different intensities on withdrawal symptoms among people with substance use disorder: a systematic review and meta-analysis.Frontiers in physiology · 2023Pooled it
- Understanding the Impacts of Novel Coronavirus Outbreaks on People Who Use Drugs: A Systematic Review to Inform Practice and Drug Policy Responses to COVID-19.International journal of environmental research and public health · 2021Pooled it
- Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.Harm reduction journal · 2022Trial
- The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services.Harm reduction journal · 2021Trial
- Spatial Patterns of Opioid Overdose Mortality Risk Across Urban, Transitional, and Rural Communities Using Satellite-Derived and Socioeconomic Indicators.Journal of urban health : bulletin of the New York Academy of Medicine · 2026Article
- County health rankings, provider shortages, and the health of incarcerated women with opioid use disorder.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2026Article
- Mind the gap: a quality improvement study to determine health care value of rapid-access telemedicine addiction treatment in recently incarcerated individuals.BMC health services research · 2025Article
- Considerations for the epidemiological evaluation of hyperlocal interventions: A case study of the New York City overdose prevention centers.Social science & medicine (1982) · 2025Article
- Understanding the use of telemedicine across different opioid use disorder treatment models: A scoping review.Journal of telemedicine and telecare · 2025Article
- Key and evolving needs of service providers in women's harm reduction centers during the COVID-19 pandemic.Harm reduction journal · 2025Article
- City-level drug policies in Portugal: the COVID-19 pandemic as an analyzer of harm reduction responsiveness in Porto and Lisbon.Harm reduction journal · 2025Article
- Racial Disparities in Outpatient Substance Use Disorder Treatment Completion: Trends and Changes from 2004 to 2024.International journal of environmental research and public health · 2025Article
- The impact of Covid-19 on harm reduction policies in Iran: an interrupted time series analysis.Harm reduction journal · 2025Article
- Giving Up the Guidelines: A Qualitative Evaluation of Disrupted Prescribing of Opioid Substitution Therapy in a Rural UK County During and Following the COVID-19 Pandemic.International journal of environmental research and public health · 2024Article
- Disparities in healthcare costs of people experiencing homelessness in Toronto, Canada in the post COVID-19 pandemic era: a matched cohort study.BMC health services research · 2024Article
- Changes in opioid treatment programs and harm reduction provider services during the COVID-19 pandemic: Findings from 10 states.Psychological services · 2024Article
- Challenges of the COVID-19 pandemic on women's HIV harm reduction centers: a mixed-methods study.Harm reduction journal · 2024Article
- World addiction medicine reports: formation of the International Society of Addiction Medicine Global Expert Network (ISAM-GEN) and its global surveys.Frontiers in psychiatry · 2024Article
- Disparities in all-cause mortality among people experiencing homelessness in Toronto, Canada during the COVID-19 pandemic: a cohort study.Frontiers in public health · 2024Article
- Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021).The International journal on drug policy · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 12 institutions in 6 countries.
Seyed Ramin RadfarDepartment of Neuroscience and Addiction, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, Iran.
Cornelis A J De JongBehavioral Science Institute Radboud University, Nijmegen, Netherlands.
Ali FarhoudianDepartment of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran.
Mohsen EbrahimiMaterials and Energy Research Center, Tehran, Iran.
Parnian RafeiDepartment of Psychology, Faculty of Psychology and Education, University of Tehran, Tehran, Iran.
Mehrnoosh VahidiDepartment of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran.
Masud YunesianSchool of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Christos KouimtsidisSurrey and Borders Partnership NHS Foundation Trust, Leatherhead, United Kingdom.
Shalini ArunogiriTurning Point, Eastern Health, Box Hill, VIC, Australia.
Omid MassahSubstance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Abbas DeylamizadehRebirth Charity Society NGO, Tehran, Iran.
Kathleen T BradyMedical University of South Carolina, Charleston, SC, United States.
Anja BusseStaff Member of Prevention, Treatment and Rehabilitation Section, Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime, Vienna, Austria.
ISAM-PPIG Global Survey Consortium
Marc N PotenzaConnecticut Council on Problem Gambling and Connecticut Mental Health Center, Yale School of Medicine, New Haven, CT, United States.
Hamed EkhtiariLaureate Institute for Brain Research, Tulsa, OK, United States.
Alexander Mario BaldacchinoSchool of Medicine, University of St Andrews, St Andrews, United Kingdom.
Tehran University of Medical Sciences · IRConnecticut Mental Health Center · USEastern Health · AULaureate Institute for Brain Research · USMedical University of South Carolina · USRadboud University Nijmegen · NLSurrey and Borders Partnership NHS Foundation Trust · GBUnited Nations Office on Drugs and Crime · ATUniversity of California, Los Angeles · USUniversity of Social Welfare and Rehabilitation Sciences · IRUniversity of St Andrews · GBUniversity of Tehran · IR
Funding
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9MAbstract
PubMed holds no abstract for this paper.
Indexed as
addiction servicesCOVID-19 pandemicdrug policyharm reductionopioid agonist treatmentpublic healthsubstance use disorder
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.